Drugmaker Strides Pharma Science has invested $15m in the first close of a series B round with a $100m target, bringing the first tranche to $35m.

Paris Saclay Seed Fund backed a series A round which will help the biotechnology company expand sales and launch a new product.

Illumina Ventures and BNP Paribas Développement have backed a series A round which will help the biotechnology company expand sales and launch a new product.

Legend Capital has put its weight behind Shanghai Cell Therapy’s $39.6m series C1 round, two years after leading a $26.6m series B.

SK China has put $266m into a new fund launched by Legend Capital that will focus on early-stage companies in the IT and healthcare sectors.

Legend-backed biotherapeutics developer Kanova has secured capital from investors including Tsinghua University-managed Lotus Lake Ventures.

Biotherapeutics developer Kanova has secured capital from investors including Tsinghua University-managed Lotus Lake Ventures.

Axa has backed a $26..2m round for the patient gifting platform, which now plans to expand into Germany, the UK and Switzerland.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

JHU-backed fitness platform operator BurnAlong obtained the cash from investors including Brown Advisory to take its total to $4.7m.